These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20520302)

  • 1. Single nucleotide polymorphism in the drug transporter gene ABCB1 in treatment-resistant depression: clinical practice.
    Rosenhagen MC; Uhr M
    J Clin Psychopharmacol; 2010 Apr; 30(2):209-11. PubMed ID: 20520302
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study.
    Menu P; Gressier F; Verstuyft C; Hardy P; Becquemont L; Corruble E
    Neuropsychobiology; 2010 Aug; 62(3):193-7. PubMed ID: 20664232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.
    Lin KM; Chiu YF; Tsai IJ; Chen CH; Shen WW; Liu SC; Lu SC; Liu CY; Hsiao MC; Tang HS; Liu SI; Chang LH; Wu CS; Tsou HH; Tsai MH; Chen CY; Wang SM; Kuo HW; Hsu YT; Liu YL
    Pharmacogenet Genomics; 2011 Apr; 21(4):163-70. PubMed ID: 20859246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    J Affect Disord; 2011 Jan; 128(1-2):56-63. PubMed ID: 20643483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.
    Mihaljevic Peles A; Bozina N; Sagud M; Rojnic Kuzman M; Lovric M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1439-44. PubMed ID: 18550244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
    Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Montgomery S; Noro M; Oswald P; Snyder L; Souery D; Zohar J; Mendlewicz J
    World J Biol Psychiatry; 2010 Dec; 11(8):985-90. PubMed ID: 20822372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.
    Chi MH; Chang HH; Lee SY; Lee IH; Gean PW; Yang YK; Lu RB; Chen PS
    J Affect Disord; 2010 Nov; 126(3):430-5. PubMed ID: 20674983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein is associated with polymorphisms of the angiotensin-converting enzyme gene in major depressed patients.
    Häfner S; Baghai TC; Eser D; Schüle C; Rupprecht R; Bondy B; Bedarida G; von Schacky C
    J Psychiatr Res; 2008 Jan; 42(2):163-5. PubMed ID: 17391703
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic studies of drug response and side effects in the STAR*D study, part 1.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
    [No Abstract]   [Full Text] [Related]  

  • 12. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
    Huuhka K; Kampman O; Anttila S; Huuhka M; Rontu R; Mattila KM; Hurme M; Lehtimäki T; Leinonen E
    Neurosci Lett; 2008 May; 437(1):25-8. PubMed ID: 18434012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic studies of drug response and side effects in the STAR*D study, part 2.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
    [No Abstract]   [Full Text] [Related]  

  • 14. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
    Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease.
    Hartmann N; Boehner M; Groenen F; Kalb R
    Depress Anxiety; 2010 Dec; 27(12):1111-6. PubMed ID: 21053332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Easing the burden of treatment-resistant depression.
    J Clin Psychiatry; 2009 Feb; 70(2):273-80. PubMed ID: 19265643
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of efficacy in lithium augmentation for treatment-resistant depression.
    Sugawara H; Sakamoto K; Harada T; Ishigooka J
    J Affect Disord; 2010 Sep; 125(1-3):165-8. PubMed ID: 20089312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of the serotonin transporter and associations with antidepressant response.
    Kraft JB; Slager SL; McGrath PJ; Hamilton SP
    Biol Psychiatry; 2005 Sep; 58(5):374-81. PubMed ID: 15993855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying "paradigm failures" contributing to treatment-resistant depression.
    Parker GB; Malhi GS; Crawford JG; Thase ME
    J Affect Disord; 2005 Aug; 87(2-3):185-91. PubMed ID: 15979725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.